NZ firm's multiple sclerosis drug gets US patent

New Zealand |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Dec, 2012

Singapore: A new drug for the treatment of secondary progressive multiple sclerosis (SPMS) called MIS416, developed by New Zealand biopharmaceutical company Innate Immunotherapeutics, has ...Read more

Digital healthcare, the next big thing

New Zealand |  Opinion | By Nandita Singh | 0 Comment | 07 Aug, 2013

A radical shift in how healthcare is delivered globally is underway. Game-changing developments in sensor technologies with applications in diagnostics, big data and mobile healthcare apps ...Read more

BS Survey: Healthcare is getting smarter in Asia

New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

...Read more

Aussies to get breast cancer treatment analysis

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2014

Singapore: Australian women will potentially have greater access to the only genomic test validated to predict whether patients with early-stage invasive breast cancer would benefit from ch...Read more

BSA-CMR Survey: APAC CROs stick to an average of 50 clients

New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

What services do APAC CROs offer to their clients?

New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

New Zealand university gets $1 mn for diabetes research

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2012

Singapore: The University of Canterbury scientists in New Zealand are seeking a major medical breakthrough in potentially identifying people most at risk of becoming diabetic. The universit...Read more

Genetically altered cow's milk to address allergies

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Singapore: Scientists at AgResearch in Hamilton, New Zealand, have bred the first cow in the world to produce high protein milk that may be hypo-allergenic. The cow's milk can exclusively a...Read more

Nylon producer Invista to collaborate with LanzaTech

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2012

Singapore: World-leading nylon producer Invista and biotechnology firm LanzaTech have signed a joint development agreement focused on bio-based butadiene. According to the agreement, Invist...Read more

Celgene halts phase III trial of cancer drug Revlimid

New Zealand |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open-label, phase III ORIGIN trial, which enrolled 450 patients in over 1...Read more

Connected care' is the new mantra of APAC healthcare

New Zealand |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

Health systems around the Asia-Pacific region and beyond are under pressure from the increasing demands of an aging population and rising rates of chronic illness. Many are responding wit...Read more

NZ, Aus govt commit $2.5 mn for rheumatic vaccine

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumatic fever has been welcomed by the University of Auckland, New Zealand....Read more

Mylan to develop, market Biocon generic insulin

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generics major, Mylan, based in Pittsburgh, US, to sell its three insulin a...Read more

Transplant pig cells into human brain to treat Parkinson's

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: Living Cell Technologies (LCT) has received ethical approval from the New Zealand Ministry of Health's Health and Disability Ethics Committee to proceed with phase I clinical tr...Read more

BioSpectrum Asia launches 5th CRO survey

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSpectrum Asia has now launched the fifth annual survey of the contract ...Read more

Largest NZ drug maker to remain a family business

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

Singapore: Douglas Pharmaceuticals, New Zealand's largest pharmaceutical manufacturer, will continue to remain a family owned business. The company had received a number of purchase offer...Read more

Nottingham university gets $25 mn for synthetic biology research

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

Singapore: The University of Nottingham has been awarded funding of $4.5 million (£2.9 million) to help make low-carbon fuel. In a move that could potentially revolutionize major UK indu...Read more

LCT conducts first implant of regenerative therapy

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment for Parkinson's disease in the first patient in phase I clinical trial....Read more